VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 200 filers reported holding VAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68,453,446 | -15.1% | 1,342,751 | -16.8% | 2.28% | -2.1% |
Q2 2023 | $80,609,253 | +83.8% | 1,614,122 | +38.0% | 2.33% | +80.2% |
Q1 2023 | $43,851,600 | -21.8% | 1,170,000 | 0.0% | 1.30% | -17.8% |
Q4 2022 | $56,101,500 | +234.2% | 1,170,000 | +37.6% | 1.58% | +642.9% |
Q1 2021 | $16,787,000 | -25.7% | 850,000 | 0.0% | 0.21% | -12.4% |
Q4 2020 | $22,585,000 | -46.2% | 850,000 | 0.0% | 0.24% | -60.5% |
Q3 2020 | $41,973,000 | +56.2% | 850,000 | 0.0% | 0.61% | +40.9% |
Q2 2020 | $26,869,000 | – | 850,000 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |